Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
43 hedge funds and large institutions have $142M invested in Global Cord Blood Corporation in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 13 closing their positions.
163% more call options, than puts
Call options by funds: $793K | Put options by funds: $302K
8% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 12
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 46 → 43 (-3)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
36% less capital invested
Capital invested by funds: $223M → $142M (-$80.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$2.49M |
| 2 |
Two Sigma Investments
New York
|
+$649K |
| 3 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$642K |
| 4 |
Norges Bank
Oslo,
Norway
|
+$564K |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$338K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JCM
Jayhawk Capital Management
Shawnee,
Kansas
|
-$16.3M |
| 2 |
Lazard Asset Management
New York
|
-$2.69M |
| 3 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$2.52M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.1M |
| 5 |
SAM
Silphium Asset Management
London,
United Kingdom
|
-$1.37M |
CO Hedge Fund Activity: Q3 2018 in Review
43 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q3 2018, worth a combined $142M — down 36% from $223M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of CO and 11 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 13 added.
The largest buyer was Renaissance Technologies, adding an estimated $2.49M. The largest seller was Jayhawk Capital Management, cutting an estimated $16.3M.
- 43 institutional investors held Global Cord Blood Corporation (CO) as of Q3 2018, down from 46 in Q2 2018.
- Funds reported $142M of Global Cord Blood Corporation stock for Q3 2018, down 36% quarter-over-quarter.
- 11 funds opened new Global Cord Blood Corporation positions in Q3 2018 and 13 closed out, a net change of -2 holders.
- The largest Global Cord Blood Corporation buyer in Q3 2018 was Renaissance Technologies, an estimated $2.49M added.
- The largest Global Cord Blood Corporation seller in Q3 2018 was Jayhawk Capital Management, an estimated $16.3M sold.
Based on aggregated 13F filings for Q3 2018.